SANDERS MORRIS HARRIS LLC - LANTERN PHARMA INC ownership

LANTERN PHARMA INC's ticker is LTRN and the CUSIP is 51654W101. A total of 27 filers reported holding LANTERN PHARMA INC in Q3 2022. The put-call ratio across all filers is 4.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
SANDERS MORRIS HARRIS LLC ownership history of LANTERN PHARMA INC
ValueSharesWeighting
Q3 2022$1,721,000
-16.3%
365,930
-0.0%
0.42%
-6.4%
Q2 2022$2,057,000
-25.1%
366,030
-4.7%
0.45%
-15.9%
Q1 2022$2,747,000
+6.7%
384,228
+14.2%
0.54%
+20.2%
Q4 2021$2,574,000336,4250.44%
Other shareholders
LANTERN PHARMA INC shareholders Q3 2022
NameSharesValueWeighting ↓
SANDERS MORRIS HARRIS LLC 384,228$2,747,0000.54%
CM Management, LLC 33,765$241,0000.20%
WOLFF WIESE MAGANA LLC 36,155$259,0000.17%
Redmond Asset Management, LLC 49,793$356,0000.11%
CARLSON CAPITAL L P 167,300$1,196,0000.08%
NewEdge Advisors, LLC 169,771$1,214,0000.02%
Sigma Planning Corp 17,600$126,0000.00%
Spire Wealth Management 4,050$29,0000.00%
WELLS FARGO & COMPANY/MN 3,558$25,0000.00%
NORTHERN TRUST CORP 12,629$90,0000.00%
View complete list of LANTERN PHARMA INC shareholders